OCGN

Ocugen Stock Price

2.06
-0.12 (-5.5%)
2.06
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Ocugen Inc OCGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.12 -5.5% 2.06 17:38:34
Open Price Low Price High Price Close Price Prev Close
2.0732 2.00 2.15 2.08 2.18
Bid Price Ask Price Spread News
2.06 2.07 0.01 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
43,743 23,394,275 $ 2.06 $ 48,210,407 86,255,326 0.17 - 3.495
Last Trade Time Type Quantity Stock Price Currency
17:38:28 3 $ 2.06 USD

Ocugen Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 333.77M 162.03M 156.81M $ - $ - -8.42 0.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Ocugen News

Date Time Source News Article
1/12/202112:06Edgar (US Regulatory)Current Report Filing (8-k)
1/12/202112:03Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)
1/12/202107:52GlobeNewswire Inc.Ocugen Inc. Announces the Cancellation of Stockholder..
1/08/202116:02Edgar (US Regulatory)Current Report Filing (8-k)
1/08/202115:17GlobeNewswire Inc.Ocugen Inc. Regains Compliance with Nasdaq Bid Price Rule
1/08/202108:00GlobeNewswire Inc.Ocugen Inc. to Present at CTIC, HC Wainwright and Noble..
1/05/202117:24Edgar (US Regulatory)Current Report Filing (8-k)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical OCGN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.44322.452.002.2618,226,797-0.3832-15.68%
1 Month2.393.4951.722.5042,805,539-0.33-13.81%
3 Months0.28993.4950.25011.8351,399,0561.77610.59%
6 Months0.44983.4950.25011.3935,564,8101.61357.98%
1 Year0.663.4950.171.1622,642,5731.40212.12%
3 Years3.243.4950.171.1218,642,382-1.18-36.42%
5 Years3.243.4950.171.1218,642,382-1.18-36.42%

Ocugen Description

Ocugen Inc is a clinical-stage biopharmaceutical company. It is focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. Ocugen offers a diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules and targets a broad range of high-need retinal and ocular surface diseases. Its product candidate includes OCU200 and OCU300 to treat diabetic macular edema (DME), diabetic retinopathy (DR) and wet age-related macular degeneration (AMD).
Your Recent History
NASDAQ
OCGN
Ocugen
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210125 22:53:36